Human FGF23/ADHR/FGFN ORF/cDNA clone-Adenovirus plasmid (NM_020638.2)
Cat. No.: pGMAD000303
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human FGF23/ADHR/FGFN adenoviral expression plasmid for FGF23 adenovirus packaging, FGF23 adenovirus.
Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.
Go to
FGF-23/FGF23/FGF23/ADHR products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMAD000303 |
| Gene Name | FGF23 |
| Accession Number | NM_020638.2 |
| Gene ID | 8074 |
| Species | Human |
| Product Type | Adenovirus plasmid (overexpression) |
| Insert Length | 756 bp |
| Gene Alias | ADHR,FGFN,HPDR2,HYPF,PHPTC |
| Fluorescent Reporter | Null |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGTTGGGGGCCCGCCTCAGGCTCTGGGTCTGTGCCTTGTGCAGCGTCTGCAGCATGAGCGTCCTCAGAGCCTATCCCAATGCCTCCCCACTGCTCGGCTCCAGCTGGGGTGGCCTGATCCACCTGTACACAGCCACAGCCAGGAACAGCTACCACCTGCAGATCCACAAGAATGGCCATGTGGATGGCGCACCCCATCAGACCATCTACAGTGCCCTGATGATCAGATCAGAGGATGCTGGCTTTGTGGTGATTACAGGTGTGATGAGCAGAAGATACCTCTGCATGGATTTCAGAGGCAACATTTTTGGATCACACTATTTCGACCCGGAGAACTGCAGGTTCCAACACCAGACGCTGGAAAACGGGTACGACGTCTACCACTCTCCTCAGTATCACTTCCTGGTCAGTCTGGGCCGGGCGAAGAGAGCCTTCCTGCCAGGCATGAACCCACCCCCGTACTCCCAGTTCCTGTCCCGGAGGAACGAGATCCCCCTAATTCACTTCAACACCCCCATACCACGGCGGCACACCCGGAGCGCCGAGGACGACTCGGAGCGGGACCCCCTGAACGTGCTGAAGCCCCGGGCCCGGATGACCCCGGCCCCGGCCTCCTGTTCACAGGAGCTCCCGAGCGCCGAGGACAACAGCCCGATGGCCAGTGACCCATTAGGGGTGGTCAGGGGCGGTCGAGTGAACACGCACGCTGGGGGAACGGGCCCGGAAGGCTGCCGCCCCTTCGCCAAGTTCATCTAG |
| ORF Protein Sequence | MLGARLRLWVCALCSVCSMSVLRAYPNASPLLGSSWGGLIHLYTATARNSYHLQIHKNGHVDGAPHQTIYSALMIRSEDAGFVVITGVMSRRYLCMDFRGNIFGSHYFDPENCRFQHQTLENGYDVYHSPQYHFLVSLGRAKRAFLPGMNPPPYSQFLSRRNEIPLIHFNTPIPRRHTRSAEDDSERDPLNVLKPRARMTPAPASCSQELPSAEDNSPMASDPLGVVRGGRVNTHAGGTGPEGCRPFAKFI |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Biosimilar | GMP-Bios-ab-086 | Pre-Made Burosumab biosimilar, Whole mAb, Anti-FGF23 Antibody: Anti-ADHR/FGFN/HFTC2/HPDR2/HYPF/PHPTC therapeutic antibody |
| Target Antibody | GM-Tg-g-T14853-Ab | Anti-FGF23/ ADHR/ FGFN functional antibody |
| Target Antigen | GM-Tg-g-T14853-Ag | FGF23 protein |
| Cytokine | cks-Tg-g-GM-T14853 | fibroblast growth factor 23 (FGF23) protein & antibody |
| ORF Viral Vector | pGMLV002454 | Human FGF23 Lentivirus plasmid |
| ORF Viral Vector | pGMAD000303 | Human FGF23 Adenovirus plasmid |
| ORF Viral Vector | pGMAD001005 | Human FGF23 Adenovirus plasmid |
| ORF Viral Vector | pGMPC001426 | Human FGF23 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMLV002454 | Human FGF23 Lentivirus particle |
| ORF Viral Vector | vGMAD000303 | Human FGF23 Adenovirus particle |
| ORF Viral Vector | vGMAD001005 | Human FGF23 Adenovirus particle |
Target information
| Target ID | GM-T14853 |
| Target Name | FGF-23/FGF23 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
8074 |
| Gene ID |
100058460 (Equus caballus), 101100063 (Felis catus), 170583 (Rattus norvegicus), 530239 (Bos taurus) 611773 (Canis lupus familiaris), 64654 (Mus musculus), 710643 (Macaca mulatta), 8074 (Homo sapiens) |
| Gene Symbols & Synonyms | FGF23,Fgf23,FGF8B,Fgf8b,ADHR,FGFN,HYPF,HFTC2,HPDR2,PHPTC |
| Target Alternative Names | ADHR,FGF-23,FGF23,FGF8B,FGFN,Fgf23,Fgf8b,Fibroblast growth factor 23,HFTC2,HPDR2,HYPF,PHPTC,Phosphatonin,Tumor-derived hypophosphatemia-inducing factor |
| Uniprot Accession |
Q8VI82,Q9EPC2,Q9GZV9
Additional SwissProt Accessions: Q8VI82,Q9EPC2,Q9GZV9 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Therapeutics Target, INN Index, Cytokine Target |
| Disease | cancer, Hypertension, Localized osteoporosis [Lequesne] |
| Disease from KEGG | MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Melanoma, Breast cancer, Gastric cancer |
| Gene Ensembl | ENSBTAG00000030343, ENSCAFG00845030660, ENSMUSG00000000182, ENSMMUG00000064833, ENSG00000118972 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


